Cargando…

Multilevel regulation of RUVBL2 expression predicts poor prognosis in hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is the second-most lethal cancer worldwide with a complex pathogenesis. RuvB-like 2 (RUVBL2) was previously found to contribute to hepatocarcinogenesis. However, its expression, regulation and clinical significance have not been systematically evaluated in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Tao, Liu, Fang, Gao, Jiajia, Lu, Haizhen, Cai, Jianqiang, Zhao, Xiaohang, Sun, Yulin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764127/ https://www.ncbi.nlm.nih.gov/pubmed/31572066 http://dx.doi.org/10.1186/s12935-019-0974-z

Ejemplares similares

UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma
por: Yang, Hao, et al.
Publicado: (2020)

Two predictive precision medicine tools for hepatocellular carcinoma
por: Zhang, Zhiqiao, et al.
Publicado: (2019)

Elevated glypican‐1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma
por: Lu, Haizhen, et al.
Publicado: (2017)

A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma
por: Ouyang, Guoqing, et al.
Publicado: (2020)

Random-forest algorithm based biomarkers in predicting prognosis in the patients with hepatocellular carcinoma
por: Guo, Lingyun, et al.
Publicado: (2020)

High AKAP8L expression predicts poor prognosis in esophageal squamous cell carcinoma
por: Luo, Qiu-yun, et al.
Publicado: (2022)

Serum alpha-fetoprotein as a predictive biomarker for tissue alpha-fetoprotein status and prognosis in patients with hepatocellular carcinoma
por: Wei, Zhewen, et al.
Publicado: (2022)

Overexpression of Chemokine (C-X-C) ligand 1 (CXCL1) associated with tumor progression and poor prognosis in hepatocellular carcinoma
por: Cao, Zhongwei, et al.
Publicado: (2014)

Cilia-associated cellular function of the AAA ATPases RUVBL1 and RUVBL2
por: Dafinger, Claudia, et al.
Publicado: (2015)

An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients
por: Zhu, Gongmin, et al.
Publicado: (2021)

A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma
por: Bu, Xiaoyun, et al.
Publicado: (2022)

Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma
por: Liu, Gao-Min, et al.
Publicado: (2019)

A novel tumor doubling time-related immune gene signature for prognosis prediction in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2021)

Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions
por: Zheng, Qiuxian, et al.
Publicado: (2021)

Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma
por: Hu, Yinan, et al.
Publicado: (2022)

Identification of RUVBL1 and RUVBL2 as Novel Cellular Interactors of the Ebola Virus Nucleoprotein
por: Morwitzer, M. Jane, et al.
Publicado: (2019)

High expression of Linc00959 predicts poor prognosis in breast cancer
por: Chi, Weiru, et al.
Publicado: (2019)

Cyclin H predicts the poor prognosis and promotes the proliferation of ovarian cancer
por: Peng, Chen, et al.
Publicado: (2020)

High PPT1 expression predicts poor clinical outcome and PPT1 inhibitor DC661 enhances sorafenib sensitivity in hepatocellular carcinoma
por: Xu, Jianjun, et al.
Publicado: (2022)

Sorafenib as an Inhibitor of RUVBL2
por: Nano, Nardin, et al.
Publicado: (2020)

High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity
por: Liu, Shouyong, et al.
Publicado: (2021)

Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma
por: Wang, Yi, et al.
Publicado: (2021)

Integrated regulation of PIKK-mediated stress responses by AAA+ proteins RUVBL1 and RUVBL2
por: Izumi, Natsuko, et al.
Publicado: (2012)

Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma
por: She, Yangyang, et al.
Publicado: (2020)

Expression of the Wnt ligands gene family and its relationship to prognosis in hepatocellular carcinoma
por: Dong, Jia-Jia, et al.
Publicado: (2019)

MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis
por: Li, Yue, et al.
Publicado: (2017)

NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

Long non-coding RNA LSAMP-1 is down-regulated in non-small cell lung cancer and predicts a poor prognosis
por: Gong, Wei, et al.
Publicado: (2022)

Study on the expression of TOP2A in hepatocellular carcinoma and its relationship with patient prognosis
por: Meng, Jiali, et al.
Publicado: (2022)

DNA methylation biomarkers for hepatocellular carcinoma
por: Fan, Guorun, et al.
Publicado: (2018)

Expression of PAWR predicts prognosis of ovarian cancer
por: Tan, Jiahong, et al.
Publicado: (2020)

Abundance of the Fanconi anaemia core complex is regulated by the RuvBL1 and RuvBL2 AAA+ ATPases
por: Rajendra, Eeson, et al.
Publicado: (2014)

KIF15 facilitates gastric cancer via enhancing proliferation, inhibiting apoptosis, and predict poor prognosis
por: Ding, Lixian, et al.
Publicado: (2020)

Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection
por: Hu, Zhi-Qiang, et al.
Publicado: (2020)

Elevated expression of LPCAT1 predicts a poor prognosis and is correlated with the tumour microenvironment in endometrial cancer
por: Zhao, Tianyi, et al.
Publicado: (2021)

Overexpression of CENPF correlates with poor prognosis and tumor bone metastasis in breast cancer
por: Sun, Jingbo, et al.
Publicado: (2019)

High CFP score indicates poor prognosis and chemoradiotherapy response in LARC patients
por: Lu, Siyi, et al.
Publicado: (2021)

UBN2 promotes tumor progression via the Ras/MAPK pathway and predicts poor prognosis in colorectal cancer
por: Zhao, Ya-li, et al.
Publicado: (2019)

Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma
por: Lv, Lei, et al.
Publicado: (2020)

Upregulated expression of DIXDC1 in intestinal-type gastric carcinoma: co-localization with β-catenin and correlation with poor prognosis
por: Wang, Lei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j24pg4s4jb75h2oihh8ukjo9gi